Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
7th Annual European Congress of Rheumatology (EULAR)
Rheumatoid Arthritis: Managing Rapidly Progressing Patients
Amsterdam, The Netherlands / June 21-24, 2006
Amsterdam - In rheumatoid arthritis (RA), there is an increasing consensus that rapidly progressing patients should be singled out for more aggressive therapy. The problem is the lack of an accepted methodology for defining a rapid...
7th Annual European Congress of Rheumatology (EULAR)
Progress in Control of Psoriatic Arthritis: Addressing Articular and Extra-articular Manifestations
Amsterdam, The Netherlands / June 21-24, 2006
Amsterdam - Biologics are being increasingly recommended upfront in the treatment of the forms of spondyloarthritis that have extra-articular manifestations, such as psoriatic arthritis, arthritis accompanied by uveitis, or arthritis...
7th Annual European Congress of Rheumatology (EULAR)
Ankylosing Spondylitis with Extra-articular Symptoms: Inflammation as the Common Denominator
Amsterdam, The Netherlands / June 21-24, 2006
Amsterdam - According to a recent survey, the majority of rheumatologists are now routinely asking patients with ankylosing spondylitis whether they have extra-articular manifestations. This is a critical change in the management of...
61st Annual Meeting of the Canadian Rheumatology Association and the 34th Mexican Congress of Rheumatology
New Targets for Optimal Disease Control in Rheumatoid Arthritis
Acapulco, Mexico / February 17-21, 2006
Acapulco - The ability to achieve “true” remission with the help of anti-tumour necrosis factor (TNF) agents has transformed the management of rheumatoid arthritis (RA). With the current anti-TNF agents, clinical remission can be achieved...